Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NMUR2 | Q9GZQ4 | 5/20 | 0.64 |
| ▸ | NMUR1 | Q9HB89 | 5/20 | 0.64 |
| ▸ | RAMP3 | O60896 | 3/20 | 0.61 |
| ▸ | CALCR | P30988 | 3/20 | 0.61 |
| ▸ | EPHA2 | P29317 | 2/20 | 0.60 |
| ▸ | NPY2R | P49146 | 5/20 | 0.58 |
| ▸ | NPY4R | P50391 | 5/20 | 0.58 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.58 |
| ▸ | NPY1R | P25929 | 4/20 | 0.58 |
| ▸ | TFPI | P10646 | 3/20 | 0.58 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31182912 | 0.91 | NPY2R (0.66) | NMUR2NMUR1CALCRNPY2RNPY4R | |
| SCHEMBL31754009 | 0.91 | MAPK8 (0.65) | NMUR2NMUR1RAMP3CALCRNPY2R | |
| SCHEMBL31182904 | 0.90 | NMUR2 (0.65) | NMUR2NMUR1RAMP3CALCRNPY2R | |
| SCHEMBL31182739 | 0.90 | NMUR2 (0.61) | NMUR2NMUR1RAMP3CALCRNPY2R | |
| SCHEMBL29562124 | 0.89 | NPY2R (0.67) | NMUR2NMUR1RAMP3CALCRNPY2R | |
| SCHEMBL30335630 | 0.89 | NMUR2 (0.64) | NMUR2NMUR1RAMP3CALCREPHA2 | |
| SCHEMBL29939144 | 0.89 | NPY2R (0.58) | NMUR2NMUR1RAMP3CALCRNPY2R | |
| SCHEMBL30495721 | 0.88 | NPY2R (0.65) | RAMP3CALCRNPY2RNPY4RNPY5R | |
| SCHEMBL29632841 | 0.88 | TFPI (0.64) | NMUR2NMUR1RAMP3CALCREPHA2 | |
| SCHEMBL29430214 | 0.87 | MAPK8 (0.61) | NMUR2NMUR1RAMP3CALCRNPY2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12509696-B2 | Methods and composition for transferring T-DNA into a plant | PURDUE RESEARCH FOUNDATION (US) | 2025-12-30 | — | — | US | disclosed |
| US-20220112510-A1 | METHODS AND COMPOSITION FOR TRANSFERRING T-DNA INTO A PLANT | PURDUE RESEARCH FOUNDATION (US) | 2022-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509696-B2 | Methods and composition for transferring T-DNA into a plant | AMPD2, MYB, TOMM22 | NMUR2 2942/4885NMUR1 4153/4885RAMP3 3514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.